comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-03 03:41:24 - browse：89188

Has PhRMA lost its fangs? Are 11th-hour changes ominous for clinical trials? And what’s next in pain medicine?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. The pharmaceutical industry, in court and in Congress, is working to water down legislation that will let Medicare negotiate certain drug prices. STAT Washington correspondent Rachel Cohrs joins us to explain the industry’s struggle to make headway — and how it factors into the 2024 election. We also discuss the latest news in the life sciences, including a twist in the future of Alnylam Pharmaceuticals, competition to Vertex Pharmaceuticals’ pain drug, and Gilead Sciences’ latest acquisition.

For more on what we cover, here’s all of Rachel’s coverage; here’s more on Vertex’s competition; here’s the news on Gilead; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： How to save PrEP access — and even expand it
Next article： Illumina slashes 2023 revenue projections yet again

hotspot

WSS

Be careful with at

Color Health wants to make cancer screenings convenient

Readout Newsletter: Beam, Prozac, "TechBio" and more

Treatments for cramps don't cut it. Why aren't there better options?

Illinois Supreme Court finds assault weapons ban constitutional

Are embryos people? Reproductive medicine's future depends on the answer

entertainment

comprehensive

Wikipedia

Guidelines to prevent youth baseball injuries need more muscle

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

Affirmative action in medical school literally saved lives

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

Peter Hotez and the public health issue of online harassment

Are embryos people? Reproductive medicine's future depends on the answer

In age of alternative facts, a scholarly course on calling out crap

Dozens dead from Maui wildfires: What we know about the victims

Walensky prepares to leave CDC — and Congress — behind

Medicare Advantage isn’t working — for anyone

Wikipedia

Using force crossed my mind when examining a defiant young patient

Laying a path for careers in science

Dozens dead from Maui wildfires: What we know about the victims

Study fuels hope CAR

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

Patients, digital health players weigh in on FTC's data privacy plan

knowledge

focus

hotspot

knowledge